CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 134 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,312,833 | -20.0% | 544,196 | 0.0% | 7.30% | -17.6% |
| Q1 2023 | $2,889,681 | -15.4% | 544,196 | 0.0% | 8.86% | -21.4% |
| Q4 2022 | $3,417,551 | -40.5% | 544,196 | 0.0% | 11.27% | -42.2% |
| Q3 2022 | $5,741,000 | +73.5% | 544,196 | -10.7% | 19.52% | +78.5% |
| Q2 2022 | $3,308,000 | -46.6% | 609,196 | -9.6% | 10.93% | +52.5% |
| Q1 2022 | $6,189,000 | -39.2% | 674,196 | 0.0% | 7.17% | +12.1% |
| Q4 2021 | $10,174,000 | -36.8% | 674,196 | 0.0% | 6.39% | -36.2% |
| Q3 2021 | $16,093,000 | – | 674,196 | – | 10.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
| Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
| PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
| Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
| Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
| Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
| Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
| Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |